Juan Romero1, Phil Larimer1, Bernard Chang1, Shira R Goldenholz1, Daniel M Goldenholz2. 1. Harvard Medical School Beth Israel Deaconess Medical Center, Department of Neurology, United States. 2. Harvard Medical School Beth Israel Deaconess Medical Center, Department of Neurology, United States. Electronic address: daniel.goldenholz@bidmc.harvard.edu.
Abstract
BACKGROUND: Changes in patient-reported seizure frequencies are the gold standard used to test efficacy of new treatments in randomized controlled trials (RCTs). Recent analyses of patient seizure diary data suggest that the placebo response may be attributable to natural fluctuations in seizure frequency, though the evidence is incomplete. Here we develop a data-driven statistical model and assess the impact of the model on interpretation of placebo response. METHODS: A synthetic seizure diary generator matching statistical properties seen across multiple epilepsy diary datasets was constructed. The model was used to simulate the placebo arm of 5000 RCTs. A meta-analysis of 23 historical RCTs was compared to the simulations. RESULTS: The placebo 50 %-responder rate (RR50) was 27.3 ± 3.6 % (simulated) and 21.1 ± 10.0 % (historical). The placebo median percent change (MPC) was 22.0 ± 6.0 % (simulated) and 16.7 ± 10.3 % (historical). CONCLUSIONS: A statistical model of daily seizure count generation which incorporates quantities related to the natural fluctuations of seizure count data produces a placebo response comparable to those seen in historical RCTs. This model may be useful in better understanding the seizure count fluctuations seen in patients in other clinical settings.
BACKGROUND: Changes in patient-reported seizure frequencies are the gold standard used to test efficacy of new treatments in randomized controlled trials (RCTs). Recent analyses of patientseizure diary data suggest that the placebo response may be attributable to natural fluctuations in seizure frequency, though the evidence is incomplete. Here we develop a data-driven statistical model and assess the impact of the model on interpretation of placebo response. METHODS: A synthetic seizure diary generator matching statistical properties seen across multiple epilepsy diary datasets was constructed. The model was used to simulate the placebo arm of 5000 RCTs. A meta-analysis of 23 historical RCTs was compared to the simulations. RESULTS: The placebo 50 %-responder rate (RR50) was 27.3 ± 3.6 % (simulated) and 21.1 ± 10.0 % (historical). The placebo median percent change (MPC) was 22.0 ± 6.0 % (simulated) and 16.7 ± 10.3 % (historical). CONCLUSIONS: A statistical model of daily seizure count generation which incorporates quantities related to the natural fluctuations of seizure count data produces a placebo response comparable to those seen in historical RCTs. This model may be useful in better understanding the seizure count fluctuations seen in patients in other clinical settings.
Authors: Eva Tlusta; Kim B Handoko; Marian Majoie; Toine C G Egberts; Jiri Vlcek; Eibert R Heerdink Journal: Epilepsia Date: 2008-08 Impact factor: 5.864
Authors: Santiago Arroyo; Henning Anhut; Alan R Kugler; Caroline M Lee; Lloyd E Knapp; Elizabeth A Garofalo; Silke Messmer Journal: Epilepsia Date: 2004-01 Impact factor: 5.864
Authors: Marc G Leguia; Ralph G Andrzejak; Christian Rummel; Joline M Fan; Emily A Mirro; Thomas K Tcheng; Vikram R Rao; Maxime O Baud Journal: JAMA Neurol Date: 2021-04-01 Impact factor: 18.302
Authors: Sharon Chiang; Rosalind W Picard; Winston Chiong; Robert Moss; Gregory A Worrell; Vikram R Rao; Daniel M Goldenholz Journal: Neurology Date: 2021-07-27 Impact factor: 11.800